Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metropolis HealthcareNSE:METROPOLIS +1.15%93 PB Ratio is 7.72 as of Aug. 25, 2026, which is 13% below its 10-year median of 8.92. GuruFocus rates NSE:METROPOLIS with a GF Score™ of 93/100 and a GF Value™ of ₹602.00 (Fairly Valued). The stock has 4 warning signs investors should review. Among 193 Medical Diagnostics & Research companies, Metropolis Healthcare ranks worse than 84.46% on this metric.
Metropolis Healthcare Ltd stock PB Ratio (=7.63) is close to 1-year high of 7.63.
The historical rank and industry rank for Metropolis Healthcare's PB Ratio or its related term are showing as below:
NSE:METROPOLIS'
s PB Ratio Range Over the Past 10 Years
Min: 5.8 Med: 8.92 Max: 21.51
Current: 7.72
During the past 11 years, Metropolis Healthcare's highest PB Ratio was 21.51. The lowest was 5.80. And the median was 8.92.
NSE:METROPOLIS's PB Ratio is ranked worse than 84.46% of 193
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.15
vs NSE:METROPOLIS: 7.72
During the past 12 months, Metropolis Healthcare's average Book Value Per Share Growth Rate was 13.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 14.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 15.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 18.70% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Metropolis Healthcare was 27.60% per year. The lowest was 14.10% per year. And the median was 16.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:METROPOLIS vs TMO, DHR, IDXX: PB Ratio Comparison
For the Diagnostics & Research subindustry, Metropolis Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metropolis Healthcare PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Metropolis Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Metropolis Healthcare (NSE:METROPOLIS) has a PB Ratio of 7.72 as of Aug. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Metropolis Healthcare and its competitors. This is 13% below median its historical median of 8.92. Over the past decade, Metropolis Healthcare's PB Ratio has ranged from 5.80 to 21.51. According to the industry distribution chart, Metropolis Healthcare ranks #163 out of 193 companies in the Medical Diagnostics & Research industry, placing it in the top 84.5%.
Is Metropolis Healthcare's PB Ratio too high?
Metropolis Healthcare's current PB Ratio of 7.72 is 13% below median its 10-year median of 8.92. Over the past 10 years, this metric has ranged from a low of 5.80 to a high of 21.51. The Medical Diagnostics & Research industry median PB Ratio is 2.15. Metropolis Healthcare's value of 7.72 is 259.1% above this industry median. Based on the distribution chart, Metropolis Healthcare ranks #163 out of 193 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Metropolis Healthcare has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metropolis Healthcare's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Metropolis Healthcare ranks #163 out of 193 companies for PB Ratio. This places Metropolis Healthcare in the lower half of its industry. The industry median PB Ratio is 2.15. Metropolis Healthcare's value of 7.72 is 259.1% above this benchmark. Historically, Metropolis Healthcare's own PB Ratio has ranged from 5.80 to 21.51 over the past decade. While the company's 10-year median is 8.92 vs. the industry median of 2.15, Metropolis Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.15, based on 193 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metropolis Healthcare's current PB Ratio of 7.72 is 259.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Metropolis Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metropolis Healthcare's current PB Ratio is 7.72, which is 13% below median its own 10-year median of 8.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metropolis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Metropolis Healthcare (NSE:METROPOLIS) is currently considered Fairly Valued. The stock's GF Value™ is ₹602.00, compared to a current price of ₹563.35 — trading 6.4% below its estimated fair value. The current PB Ratio is 7.72, which is 13% below median its 10-year median of 8.92 and 259.1% above the Medical Diagnostics & Research industry median of 2.15. Metropolis Healthcare's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Metropolis Healthcare (NSE:METROPOLIS), the current PB Ratio is 7.72 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metropolis Healthcare (NSE:METROPOLIS) Overvalued in 2026?
Based on GuruFocus' analysis, Metropolis Healthcare stock appears to be undervalued.
The current stock price of ₹563.35 is trading 6.4% below its estimated GF Value™ of ₹602.00.
GuruFocus considers Metropolis Healthcare to be Fairly Valued.
Key valuation signals for NSE:METROPOLIS:
PB Ratio: 7.72 (13% below median its 10-year median of 8.92)
GF Value™: ₹602.00 vs. price of ₹563.35 (6.4% below fair value)
Industry Position: 259.1% above the Medical Diagnostics & Research median (#163 of 193)
No single metric tells the full story. See the NSE:METROPOLIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
93GF Score
Get the complete analysis for NSE:METROPOLIS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:METROPOLIS has been successfully added to your 
